Discovery Labs posts 3Q loss in prep for drug approval

Discovery Laboratories Inc. reported today reported a net loss of $10.6 million (or $0.11 per share) for the third quarter, compared with a net loss of $9.3 million (or $0.11 per share) for the same period in 2007.